Nomura Holdings’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.03M | Sell |
33,500
-39,500
| -54% | -$2.3M | 0.01% | 925 |
|
|
2025
Q4 | $3.94M | Hold |
73,000
| – | – | 0.01% | 865 |
|
|
2025
Q3 | $3.29M | Buy |
73,000
+30,000
| +70% | +$1.4M | 0.01% | 942 |
|
|
2025
Q2 | $1.99M | Hold |
43,000
| – | – | ﹤0.01% | 837 |
|
|
2025
Q1 | $2.62M | Buy |
43,000
+38,000
| +760% | +$2.21M | ﹤0.01% | 949 |
|
|
2024
Q4 | $283K | Buy |
+5,000
| New | +$279K | ﹤0.01% | 1984 |
|
|
2024
Q2 | – | Sell |
-40,000
| Closed | -$2.17M | – | 1770 |
|
|
2024
Q1 | $2.17M | Sell |
40,000
-45,500
| -53% | -$2.32M | 0.01% | 882 |
|
|
2023
Q4 | $4.39M | Sell |
85,500
-7,400
| -8% | -$388K | 0.01% | 707 |
|
|
2023
Q3 | $5.39M | Buy |
92,900
+7,400
| +9% | +$453K | 0.02% | 510 |
|
|
2023
Q2 | $5.47M | Buy |
+85,500
| New | +$5.73M | 0.01% | 472 |
|
|
2023
Q1 | – | Sell |
-1,664,600
| Closed | -$115M | – | 1473 |
|
|
2022
Q4 | $115M | Buy |
1,664,600
+560,900
| +51% | +$42.3M | 0.47% | 36 |
|
|
2022
Q3 | $75.5M | Buy |
1,103,700
+693,900
| +169% | +$50.3M | 0.31% | 60 |
|
|
2022
Q2 | $30M | Buy |
409,800
+405,900
| +10,408% | +$30.9M | 0.1% | 121 |
|
|
2022
Q1 | $275K | Sell |
3,900
-520,000
| -99% | -$34.9M | ﹤0.01% | 1475 |
|
|
2021
Q4 | $31.6M | Buy |
523,900
+116,800
| +29% | +$6.85M | 0.08% | 177 |
|
|
2021
Q3 | $23.7M | Buy |
407,100
+44,600
| +12% | +$2.94M | 0.06% | 189 |
|
|
2021
Q2 | $23.4M | Buy |
362,500
+8,600
| +2% | +$561K | 0.06% | 186 |
|
|
2021
Q1 | $21.6M | Buy |
+353,900
| New | +$22M | 0.05% | 197 |
|
|
2020
Q1 | – | Sell |
-58,000
| Closed | -$3.58M | – | 930 |
|
|
2019
Q4 | $3.58M | Sell |
58,000
-16,100
| -22% | -$922K | 0.01% | 511 |
|
|
2019
Q3 | $3.7M | Hold |
74,100
| – | – | 0.01% | 531 |
|
|
2019
Q2 | $3.41M | Sell |
74,100
-2,333,600
| -97% | -$109M | 0.02% | 574 |
|
|
2019
Q1 | $114M | Buy |
+2,407,700
| New | +$120M | 0.48% | 34 |
|
|
2017
Q2 | – | Sell |
-50,000
| Closed | -$2.74M | – | 1460 |
|
|
2017
Q1 | $2.74M | Sell |
50,000
-50,000
| -50% | -$2.74M | 0.01% | 608 |
|
|
2016
Q4 | $5.85M | Hold |
100,000
| – | – | 0.01% | 510 |
|
|
2016
Q3 | $5.43M | Hold |
100,000
| – | – | 0.02% | 412 |
|
|
2016
Q2 | $7.33M | Hold |
100,000
| – | – | 0.02% | 347 |
|
|
2016
Q1 | $6.37M | Buy |
+100,000
| New | +$6.31M | 0.02% | 308 |
|
|
2014
Q4 | – | Sell |
-149,500
| Closed | -$7.64M | – | 2307 |
|
|
2014
Q3 | $7.64M | Buy |
149,500
+89,900
| +151% | +$4.49M | 0.02% | 529 |
|
|
2014
Q2 | $2.9M | Sell |
59,600
-8,600
| -13% | -$424K | ﹤0.01% | 948 |
|
|
2014
Q1 | $3.55M | Buy |
+68,200
| New | +$3.63M | ﹤0.01% | 896 |
|
Other funds holding BMY
VCM
VPM
Nomura Holdings's BMY Position: Q1 2026 in Review
Nomura Holdings reduced its Bristol-Myers Squibb (BMY) stake by 71% in Q1 2026, selling an estimated $2.47M and leaving 17,531 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #1141.
Nomura Holdings first reported a position in BMY in Q2 2013 and has held it in 50 quarters since. The position peaked at $133M in Q1 2019. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Nomura Holdings held 17,531 shares of Bristol-Myers Squibb worth $1.06M as of Q1 2026.
- Nomura Holdings sold 42,392 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.47M.
- Bristol-Myers Squibb made up ﹤0.01% of Nomura Holdings's portfolio in Q1 2026, its #1141 holding.
- Nomura Holdings first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 50 quarters since.
- Nomura Holdings's Bristol-Myers Squibb position peaked at $133M in Q1 2019.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.